Considering that the final goal of cancerous cells relies on surviving at all costs, the reported association between the optimization of DDR through ATM/ATR/p53 axis upregulation and the tolerance to chemotherapeutic drugs such as gemcitabine in pancreatic cancer is not surprising at all [56]. This evidence concerns the gene ATM and pancreatic neoplasm.